ArticleFrontiers in microbiology2018
Further Spread of a
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 19 citations in OpenAlex.
- Identification of a novel circular DNA carrying blaBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025Article
- Emergence of carbapenem-resistantMicrobiology spectrum · 2025Article
- Characterization of a Novel Carbapenem-Resistant Klebsiella michiganensis Strain Coharboring the blaCurrent microbiology · 2022Article
- Analysis of the molecular characteristics of a blaKPC-2-harbouring untypeable plasmid in Serratia marcescens.International microbiology : the official journal of the Spanish Society for Microbiology · 2022Article
- Genetic and virulence characteristics of a Raoultella planticola isolate resistant to carbapenem and tigecycline.Scientific reports · 2022Article
- Molecular Mechanisms and Epidemiology of Carbapenem-ResistantInfection and drug resistance · 2021Article
- Emerging Transcriptional and Genomic Mechanisms Mediating Carbapenem and Polymyxin Resistance inmSystems · 2020Review
- Novel IncR/IncP6 Hybrid Plasmid pCRE3-KPC Recovered from a Clinical KPC-2-Producing Citrobacter braakii Isolate.mSphere · 2020Article
- Genetic Factors Associated with EnhancedAntimicrobial agents and chemotherapy · 2020Article
- Molecular Mechanisms and Epidemiology of Carbapenem-ResistantInfection and drug resistance · 2020Article
- Comparative Analysis ofAntimicrobial agents and chemotherapy · 2019Article
- Characterization of Antimicrobial Resistance inMicroorganisms · 2019Article
- Plasmid-Mediated Transmission of KPC-2 Carbapenemase inFrontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The wide spread of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.